In Vitro Technologies
In Vitro Technologies is a private Australian-owned specialty distributor and OEM-certified technical service provider of medical, scientific, and diagnostic equipment across Australia and New Zealand, serving hospitals, laboratories, NICUs, and women's health facilities through four business units under exclusive global brand agreements.
- Company typePrivate
- Founded2002
- HeadquartersNoble Park, Australia
- Headcount101–250
- GTM typeB2B
- OfferingHardware or Manufacturing
What In Vitro Technologies does
In Vitro Technologies Pty. Ltd. is a private, 100% Australian-owned specialty medical and scientific equipment distributor and technical service provider, founded in 2002 and headquartered in Noble Park North, Victoria. The company operates across Australia and New Zealand through a national distribution network shipping from Melbourne, Perth, Brisbane, and Sydney, and an Auckland office. It is wholly owned by multi-generational family conglomerate JJ Richards & Sons Pty Ltd and employs more than 1,200 people. The business is organised into four specialised business units: Life Sciences (research reagents, ELISA kits, antibodies, cell biology tools from brands such as Bio-Techne's R&D Systems, Tocris, Novus Biologicals, ACD Bio); Infection Control (sterilisation, disinfection, washer disinfectors, traceability software from Steelco, Matachana, Miele, Aktormed, Borer); Women's & Children's Health (obstetric diagnostics, neonatal devices, fetal monitoring from QIAGEN's AmniSure and PartoSure, Neotech, Medinvent's EPISCISSORS-60, CCD Pipelle, Stephan ventilators, Huntleigh/Sonicaid); and Infrastructure & Engineering (capital project services including CSSD system planning). The company is the exclusive AU/NZ distributor for most of the brands it carries, and operates the only OEM-certified repair facility in market, with regionalised factory-trained service engineers across Adelaide, Brisbane, Melbourne, Sydney, and Perth.
The company makes money primarily through capital equipment sales and recurring consumables distribution, with a secondary revenue stream from multi-year technical service agreements covering installation, preventive maintenance, and repair (labour rates of $450/hr outside normal hours, $550/hr on weekends and public holidays, with minimum 4-hour callout charges). Distribution is quote-based with publicly listed freight and handling fees ($66.20 ex GST metropolitan, $84.30 ex GST regional, plus equipment handling, security freight, dry ice, and emergency fuel surcharges effective 4 May 2026). The go-to-market is sales-led, combining field sales for enterprise hospital and laboratory accounts, inside sales through a customer care centre reachable via 1300 552 003, and an online quote/contact-specialist portal. Customer segments are enterprise B2B across hospitals, healthcare facilities, research laboratories, scientific institutions, NICUs, maternity wards, and women's health units. The company holds ISO 9001 certification and ships cold chain orders from Melbourne on Tuesdays and Thursdays, with ambient/equipment orders shipping Mondays, Wednesdays, and Fridays from four hubs.
In Vitro does not develop proprietary core technology platforms; its competitive position rests on exclusive OEM distribution rights, OEM-certified technical service capability, and a national ANZ field service network that competitors cannot replicate without negotiated access to each underlying manufacturer. Recent strategic activity has focused on expanding exclusive distribution partnerships (notably Neotech in February 2020, Bio-Techne brands, Steelco, and Medinvent) and adding adjacent product lines such as Aktormed's SOLOASSIST II robotic endoscopy platform, while extending operations through a fourth Infrastructure & Engineering business unit targeting capital project integration.
In Vitro Technologies firmographics
Firmographics- Name
- In Vitro Technologies
- Legal name
- In Vitro Technologies Pty. Ltd.
- Website
- https://invitro.com.au
- Company type
- Private
- Founded year
- 2002
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- In Vitro Technologies is a private Australian-owned specialty distributor and OEM-certified technical service provider of medical, scientific, and diagnostic equipment across Australia and New Zealand, serving hospitals, laboratories, NICUs, and women's health facilities through four business units under exclusive global brand agreements.
- Ownership category
- akta.pro rank
In Vitro Technologies industry classification
Industry- Product category
- Medical and Scientific Equipment Distribution
- NAICS
- Medical Equipment and Supplies Manufacturing (3391)
- SIC
- Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047), Wholesale-Professional & Commercial Equipment & Supplies (5040)
- akta.pro primary industry
- Laboratory Consumables & Plasticware (Tips, Tubes, Plates, Filters) (HLAGAIAH)
Keywords
Where In Vitro Technologies is headquartered
LocationHeadquarters
- HQ city
- Noble Park
- HQ country
- Australia
- HQ region
- Oceania
Offices7 records
Markets served
In Vitro Technologies business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Operations, Supply Chain, Marketing or Sales, Technology or R&D, Infrastructure
Revenue model
- Medical and Scientific Equipment Distribution: In Vitro Technologies generates revenue primarily through the distribution of medical, scientific, and diagnostic equipment and consumables. Revenue is derived from the sale of capital equipment (e.g., washers, sterilisers, fetal monitors), consumables (e.g., lancets, electrodes, test kits), and associated spare parts. The company also earns revenue from service agreements covering installation, maintenance, and repair of equipment, which include labour charges and parts.
- Technical Service and Maintenance Contracts: The company provides service agreements for the equipment they distribute, including preventive maintenance, repair, and technical support. Service terms are documented in formal agreements with customers, with labour charged at standard and overtime rates. Outside normal working hours, minimum 4-hour charges apply at $450 per hour labour and travel, or $550 per hour on weekends and public holidays.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Pay-as-you-go | Freight & Handling - Metropolitan areas |
| Other | Pay-as-you-go | Freight & Handling - Regional areas |
| Other | Pay-as-you-go | Standard Equipment Handling |
| Other | Pay-as-you-go | Security Freight |
| Other | Pay-as-you-go | Dry Ice Surcharge |
| Other | Pay-as-you-go | Emergency Fuel Surcharge - Local deliveries (from 4 May 2026) |
| Other | Pay-as-you-go | Emergency Fuel Surcharge - Regional deliveries (from 4 May 2026) |
| Other | Pay-as-you-go | Emergency Fuel Surcharge - Cold Chain deliveries (from 4 May 2026) |
| Other | Multi-year contract | Service Labour - Normal Working Hours |
| Other | Pay-as-you-go | Service Labour - Outside Normal Hours (Weekdays) |
| Other | Pay-as-you-go | Service Labour - Weekends and Public Holidays |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels5 records
In Vitro Technologies product offering
Product offeringCore offering
In Vitro Technologies is a B2B distributor of medical, scientific, and diagnostic equipment, instruments, and consumables across Australia and New Zealand, organised into three specialised divisions (Life Sciences, Infection Control, Women's & Children's Health). The company sells capital equipment (washer disinfectors, sterilisers, fetal monitors, neonatal ventilators), consumables (lancets, electrodes, test kits, disposable linen), and provides certified installation, preventive maintenance, and OEM-standard repair services through a regionalised technical service engineering team.
Product overview
In Vitro Technologies operates as a multi-division medical and scientific product distribution company organized into four specialized business units: Life Sciences (research tools, antibodies, ELISA kits, cell biology products), Women's & Children's Health (diagnostic tests, fetal monitoring, neonatal devices), Infection Control (sterilization equipment, washer disinfectors, traceability software), and Technical Services (installation, maintenance, repair). The company distributes products from global manufacturers including Bio-Techne brands (R&D Systems, Tocris, Novus Biologicals, ACD Bio), Steelco, Matachana, Aktormed, Miele Medical, AmniSure, PartoSure, CCD, Neotech, Huntleigh/Sonicaid, Stephan, Medinvent, CooperSurgical, and Segetex. Technical Services provides installation and repair support exclusively for distributed equipment. The product portfolio spans diagnostic tests (ROM tests, preterm birth tests, endometrial sampling), medical devices (neonatal ventilators, ECG electrodes, suction devices), surgical equipment (robotic endoscopes, episiotomy scissors), sterilization/cleaning systems (washers, sterilizers, ultrasonic cleaners, traceability software), and disposable healthcare supplies (linen, protective equipment).
Differentiator
Problem solved
Functional benefit
Brands
- Life Sciences: Life science products and solutions division of In Vitro Technologies.
- Women's & Children's
- Infection Control
- Technical Services
- Customer Care
Products and services
- Steelco Washer Disinfector (Large Capacity) Large capacity instrument washer disinfectors for hospital central sterile services departments (CSSD) and healthcare facilities, sold and serviced in Australia as part of the Steelco infection control range.
- Steelco Trolley Washer Disinfector Trolley-mounted washer disinfectors for processing surgical trolleys and large equipment in healthcare settings.
- SteelcoData Live Web-based and cloud-ready cycle traceability software for monitoring CSSD and endoscopy department device performance, cycles, and consumptions.
- Steelco Endoscopic Reprocessing (ARES) Automated endoscopic reprocessing systems for high-level disinfection of flexible endoscopes.
- Steelco Ultrasonics Ultrasonic cleaning equipment for medical instrument reprocessing in healthcare facilities.
- Steelco Steam Sterilizers Steam sterilizers for sterilization of medical and surgical instruments in healthcare settings.
- Matachana Steam Sterilizers Steam sterilization equipment for medical instrument processing in hospitals and healthcare facilities.
- Matachana Low Temperature Sterilizers Low temperature sterilization systems for heat-sensitive medical devices.
- Borer Instrument Chemicals Reprocessing chemistry and cleaning chemicals for medical instrument decontamination.
- AmniSure Rapid bedside test for diagnosis of ruptured fetal membranes (ROM/PROM) using PAMG-1 biomarker with 99% accuracy, recommended by RANZCOG guidelines.
- PartoSure Rapid non-invasive strip test for detection of placental alpha microglobulin-1 (PAMG-1) to assess risk of preterm birth within 7-14 days.
- CCD Pipelle de Cornier Disposable endometrial aspiration device for outpatient endometrial sampling and cancer screening, considered the gold standard in endometrium sampling.
- CCD Pipelle de Cornier Mark II Patented endometrial sampling device with surface-treated tip for combined cytology and histology specimen collection.
- CCD Pipelle H Extended-length (50cm) Pipelle device for endometrial sampling during diagnostic hysteroscopy procedures.
- Unistik Heelstik Heel incision device designed for neonatal capillary sampling with penetration depths calibrated for preterm, full term, and toddlers to minimize discomfort.
- Neotech Little Sucker Patented oral and nasal suction device for neonatal and pediatric care with soft flexible tip and optional protective cover.
- Neotech NeoLead ECG Electrodes Radiolucent ECG electrodes designed for infants with hydrocolloid adhesive and multi-colored wires for easier identification.
- Neotech NeoPulse Lightweight adjustable disposable pulse oximeter wrap in three sizes for neonatal and pediatric patients.
- Neotech NeoShades Phototherapy eye shields with NeoFoam headstrap for protecting neonatal eyes during jaundice treatment.
- Neotech NeoSeal Nasal prongs seal that adheres to prongs rather than infant skin, protecting fragile nasal septum during respiratory support.
- Neotech NeoSmile Temperature probe cover with NeoBond hydrocolloid base for secure and skin-friendly temperature monitoring.
- Episcissors-60 Surgical scissors designed to give accurate 60-degree mediolateral episiotomy to reduce OASIS (obstetric anal sphincter injuries) during childbirth.
- Stephan F120 Mobile Respiratory System Mobile respiratory system designed for children's intensive care units and emergency transport of newborns requiring ventilation.
- Stephan EasyFlow nCPAP Nasal CPAP system with nasal prongs and masks designed for premature and newborn ventilation support.
- CooperSurgical TransWarmer Thermal warming device for maintaining infant temperature during medical procedures and transport.
- Sonicaid Team 3 Fetal/Maternal Monitor Fetal and maternal monitoring system with touchscreen interface, Dawes-Redman CTG analysis, and support for single, twins, or triplets monitoring.
- Sonicaid Digital SR2/SR3 Waterproof Dopplers Waterproof handheld fetal Dopplers with fixed 2MHz or 3MHz probes for fetal heart detection from early pregnancy through labor.
- Solo Assist II Robotic assistance system for guiding endoscopes in minimally invasive surgery across general surgery, urology, and gynecology.
- R&D Systems Research Reagents Research tools including highly verified ELISA kits, biologically active cytokines, and validated antibodies for medical research and diagnostics.
- Tocris Pharmacological Compounds Bio-Techne brand offering pharmacological compounds and tools for life science research.
- Novus Biologicals Antibodies Bio-Techne brand providing antibodies and research reagents for scientific research.
- ACD Bio RNA Detection Solutions Bio-Techne brand specializing in RNA detection and analysis solutions including RNAscope technology.
- Technical Service and Maintenance Agreements Installation, preventive maintenance, repair, and technical support services for the equipment In Vitro distributes, delivered by factory-trained regional service engineers across Adelaide, Brisbane, Melbourne, Sydney, and Perth. As exclusive distributor, In Vitro is the only facility capable of restoring equipment to OEM specifications.
Quantifiable outcome
- AmniSure achieves 99% accuracy in diagnosing premature rupture of fetal membranes (PROM), outperforming conventional tests such as nitrazine, ferning, pooling and ultrasound
- +4 more outcomes
Companies that use In Vitro Technologies
Customer profileNamed customers3 records
Ideal customer profiles3 records
In Vitro Technologies technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
In Vitro Technologies partnerships and signals
Strategic signalPartnerships
13 partnerships are on record, tiered core and secondary.
- SteelcocoreSteelco is a leading global provider of medical cleaning, disinfection, and sterilisation equipment including washer disinfectors, steam sterilisers, low-temperature sterilisers, and the SteelcoData Live traceability software. In Vitro Technologies is the exclusive Australian distributor for Steelco's medical range. In Vitro provides technical support, system planning for CSD, and customised layout configurations for project installations of Steelco equipment.
- Bio-Techne (R&D Systems, Tocris, Novus Biologicals, ACD Bio)coreBio-Techne is a global manufacturer of research tools including recombinant proteins, antibodies, ELISA kits, stem cell products, and assay reagents. In Vitro Technologies distributes Bio-Techne's brands (R&D Systems, Tocris, Novus Biologicals, ACD Bio) in Australia and New Zealand. The partnership is positioned as a unified scientific offering to help researchers attain their goals.
- Owen MumfordcoreOwen Mumford is a global medical device manufacturer specialising in blood sampling and injection devices. In Vitro distributes Owen Mumford's Unistik heel incision devices (including Unistik Heelstik) in Australia and New Zealand, designed to minimise discomfort for babies and infants during capillary blood sampling.
- Laboratoire CCDcoreLaboratoire CCD is a French pharmaceutical and medical device company with over 60 years of expertise in women's health and reproductive medicine. In Vitro Technologies distributes CCD's Pipelle range of endometrial sampling devices (Pipelle de Cornier, Pipelle de Cornier Mark II, Pipelle H) in the Australian and New Zealand markets, supporting gynaecology, fertility, and assisted reproduction.
- StephancoreStephan is a German manufacturer and industry leader in ventilation systems for premature and newborn infants. In Vitro Technologies distributes Stephan's respiratory systems (F120 mobile respiratory system, SOPHIE and STEPHANIE ventilators) and EasyFlow nCPAP accessories in Australia and New Zealand, serving neonatal intensive care units and children's intensive care settings.
- NeotechcoreNeotech is an essential brand in NICU around the world providing medical devices for PICU and children's oncology. In Vitro Technologies is the exclusive Australian and New Zealand distributor for Neotech products including NeoBond, NeoFoam-based devices, Little Sucker, NeoLead ECG electrodes, NeoShades, NeoPulse, and NeoSeal. The partnership was announced in February 2020.
- MatachanacoreMatachana is a manufacturer of steam sterilisers and low-temperature sterilisation systems. In Vitro Technologies distributes Matachana products as part of its infection control portfolio, complementing the Steelco sterilisation range.
- Miele Medical RangesecondaryMiele is a premium manufacturer of commercial and medical-grade washer disinfectors. In Vitro distributes the Miele medical range as part of its infection control and instrument reprocessing solutions.
- Aktormed (SOLOASSIST II)secondaryAKTORmed is the German market leader in robotic assistance systems guiding endoscopes in minimally invasive surgery. The SOLOASSIST II platform offers flexibility and operability for general surgery, urology, and gynaecology interventions. Distributed in Australia and New Zealand by In Vitro Technologies.
- AmniSure (QIAGEN)coreAmniSure is a rapid non-invasive test for diagnosis of ruptured fetal membranes (PROM), using the PAMG-1 biomarker for 99% accuracy. In Vitro distributes AmniSure in Australia and New Zealand. The product is recommended by RANZCOG guidelines in the diagnosis of term PROM.
- PartoSure (QIAGEN)corePartoSure is a rapid non-invasive strip test for detecting PAMG-1 in cervicovaginal secretions to predict imminent preterm delivery. Distributed in Australia and New Zealand by In Vitro Technologies, targeting obstetric units and labour wards.
- Huntleigh (Sonicaid)coreHuntleigh (incorporating Sonicaid) is a global provider of medical equipment for obstetrics, vascular assessment, and patient monitoring. In Vitro distributes Huntleigh's fetal/maternal monitors (Sonicaid Team 3 Series), waterproof digital Dopplers (SR2/SR3), and accessories in Australia and New Zealand.
- MedinventcoreMedinvent is the UK manufacturer of EPISCISSORS-60, the first scissors designed to achieve a precise 60-degree mediolateral episiotomy angle, reducing the risk of obstetric anal sphincter injuries (OASIS). Used in over 60% of NHS hospitals in England and in Europe, Canada, Australia, New Zealand, and the Middle East. In Vitro Technologies is the AU/NZ supplier.
Scale indicators4 records
Recent moves6 records
Expansion highlights4 records
In Vitro Technologies competitors and assessment
Company assessmentBroad incumbents
- Stryker: Global medical device manufacturer with significant AU/NZ presence. Competes with In Vitro's Women's & Children's Health and surgical equipment distribution across multiple product categories, including endoscopy, women's health, and procedural equipment sold to hospitals.
- GE HealthCare: Global medical equipment and life sciences manufacturer with significant AU operations. Competes broadly with In Vitro across patient monitoring, imaging, fetal monitoring (overlapping with Huntleigh Sonicaid), and life sciences product categories sold to hospitals and research institutions.
- Olympus Medical: Global medical device manufacturer specialising in endoscopy and minimally invasive surgery with AU operations. Overlaps with In Vitro's distribution of Aktormed SOLOASSIST II robotic endoscopy assistance and broader surgical equipment portfolio served to hospitals.
- Bio-Rad Laboratories: Global life science research tools manufacturer with AU/NZ presence. Competes with In Vitro's Life Sciences division in research reagents, antibodies, and lab equipment distribution, paralleling the Bio-Techne brands (R&D Systems, Tocris) In Vitro distributes.
- STERIS: Global sterilization and infection prevention company with AU/NZ presence. Competes with In Vitro's Infection Control division offering washer disinfectors, steam sterilisers, low-temperature sterilisers, and CSSD consumables directly to hospitals, paralleling In Vitro's Steelco and Matachana portfolio.
- Hologic: Global women's health diagnostics manufacturer with AU presence. Competes with In Vitro's Women's & Children's Health division in OB/GYN diagnostics, fetal health assessments, and similar clinical products, paralleling the AmniSure and PartoSure distribution business.
- Thermo Fisher Scientific: Global life sciences tools and laboratory equipment manufacturer with AU/NZ operations. Competes with In Vitro's Life Sciences division in research tools, reagents, cell biology products, and lab consumables, offering an alternative to the Bio-Techne brands In Vitro distributes.
- Getinge: Global leader in sterilization, infection control, and surgical workflows with AU/NZ operations. Competes directly with In Vitro's Infection Control division through direct sales of washers, sterilisers, and CSSD solutions, and competes with the Steelco/Matachana brands In Vitro distributes.
Direct peers
- Medline Industries: Global medical supplies manufacturer and distributor with Australian operations. Competes with In Vitro in medical/surgical supply distribution, offering similar healthcare facility solutions and capital equipment portfolios to hospitals and clinics across AU/NZ.
- Device Technologies: Australia and New Zealand's largest independent medical device distributor, distributing surgical, medical, and scientific equipment. Most direct competitor to In Vitro with similar distribution model, exclusive brand agreements, and national technical service footprint across the same hospital customer base.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
In Vitro Technologies social profiles
Digital presenceIn Vitro Technologies compliance and trust
Trust signalCompliance1 record
In Vitro Technologies financial estimates
Financial estimateRevenue estimate
Valuation estimate
In Vitro Technologies leadership team
Management profileNumber of profiles
In Vitro Technologies funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
In Vitro Technologies M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about In Vitro Technologies
What does In Vitro Technologies do?
In Vitro Technologies is a B2B distributor of medical, scientific, and diagnostic equipment, instruments, and consumables across Australia and New Zealand, organised into three specialised divisions (Life Sciences, Infection Control, Women's & Children's Health). The company sells capital equipment (washer disinfectors, sterilisers, fetal monitors, neonatal ventilators), consumables (lancets, electrodes, test kits, disposable linen), and provides certified installation, preventive maintenance, and OEM-standard repair services through a regionalised technical service engineering team.
Is In Vitro Technologies a public or private company?
In Vitro Technologies is a private company. It is classified as family owned and is currently operating.
When was In Vitro Technologies founded?
In Vitro Technologies was founded in 2002. It employs 101 to 250 people.
Where is In Vitro Technologies based?
In Vitro Technologies is headquartered in Noble Park, Australia, in the Oceania region.
How does In Vitro Technologies make money?
Two revenue lines are on record. Medical and Scientific Equipment Distribution is the primary driver. The others are technical Service and Maintenance Contracts.
Who are In Vitro Technologies's main competitors?
Broad incumbents on record are Stryker, GE HealthCare, Olympus Medical, Bio-Rad Laboratories, STERIS, Hologic, Thermo Fisher Scientific and Getinge. Direct peers are Medline Industries and Device Technologies.
Does In Vitro Technologies have an API?
No public API is recorded for In Vitro Technologies.
What industry is In Vitro Technologies in?
In Vitro Technologies's product category is Medical and Scientific Equipment Distribution. Its primary akta.pro industry code is HLAGAIAH, Laboratory Consumables & Plasticware (Tips, Tubes, Plates, Filters). Its NAICS code is 3391 and its SIC code is 5047.